BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35839054)

  • 1. Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
    Horiuchi Y; Hashimoto K; Horikoshi H; Sano A; Kawamura Y; Fujita N; Kimata M; Ono Y; Obuchi Y; Makino A; Kaneko M; Kimura F; Itoh K; Tanaka Y
    Medicine (Baltimore); 2022 Jul; 101(28):e29354. PubMed ID: 35839054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
    Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2022; 13():822169. PubMed ID: 35116046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
    Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
    BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome.
    Yamashita S; Furukawa NE; Matsunaga T; Hirakawa Y; Tago M; Yamashita SI
    Am J Case Rep; 2017 Dec; 18():1296-1301. PubMed ID: 29208852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
    Yamabe T; Ohmura SI; Uehara K; Naniwa T
    Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
    Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
    Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
    Kawasaki T; Ooka S; Mizushima M; Nakamura Y; Ikeda H; Sakurada T; Suzuki S; Yamazaki K; Goto Y; Sakurai K; Yukitaka Y; Kiyokawa T; Tonooka K; Kunishima H; Kawahata K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):101-105. PubMed ID: 34592766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heliotrope-like manifestation of adult-onset Still disease with macrophage activation syndrome: A case-based review.
    Ikeda T; Yokoyama K; Kawakami T
    J Dermatol; 2022 Jul; 49(7):736-740. PubMed ID: 35438204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
    Kadavath S; Zapantis E; Zolty R; Efthimiou P
    Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in a patient with new adult-onset Still disease: A case report.
    Alharbi SO
    Medicine (Baltimore); 2022 Oct; 101(40):e30953. PubMed ID: 36221437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
    Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of recurrence of adult-onset Still's disease in the third trimester: a case report and literature review.
    Hosoya S; Sadatsuki M; Izuka S; Yamashita H; Oishi H
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):163. PubMed ID: 33627085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A.
    Kawaguchi H; Tsuboi H; Yagishita M; Terasaki T; Terasaki M; Shimizu M; Honda F; Ohyama A; Takahashi H; Miki H; Yokosawa M; Asashima H; Hagiwara S; Kondo Y; Matsumoto I; Sumida T
    Intern Med; 2018 Apr; 57(7):1033-1038. PubMed ID: 29269680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory adult-onset Still's disease complicated with monoclonal gammopathy of undetermined significance: A case report.
    Saito K; Asano T; Matsumoto H; Fujita Y; Matsuoka N; Ohkawara H; Sumichika Y; Yoshida S; Temmoku J; Yashiro-Furuya M; Sato S; Watanabe H; Migita K
    Medicine (Baltimore); 2022 Dec; 101(49):e32107. PubMed ID: 36626532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Profiling Serum IL-18 and Neopterin in Diagnosis of Adult-Onset Still's Disease Complicated by Pulmonary Tuberculosis: A Case Report.
    Kamada M; Kenzaka T
    Tohoku J Exp Med; 2020 Apr; 250(4):201-206. PubMed ID: 32238618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
    Bindoli S; Galozzi P; Doria A; Sfriso P
    Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.